Grifols stock pre-market at EUR 10.14: plasma therapies group trades
Published on 10/26/2026 at 08:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBusiness model and market
- Grifols develops, manufactures, and distributes plasma-derived therapeutic products.
- Spain is Grifols' home market on October 26, 2026.
- Grifols stock trades pre-market at EUR 10.14 at 8:16 a.m. CET at Lang & Schwarz on October 26, 2026.
Grifols develops, manufactures, and distributes therapeutic products, with a primary focus on treatments derived from human plasma. The stock trades pre-market at EUR 10.14 at 8:16 a.m. CET at Lang & Schwarz on October 26, 2026.
Ahead of the Xetra open
Lang & Schwarz shows a bid of EUR 10.07 and an ask of EUR 10.21, representing a 1.38 percent spread. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Grifols stock.
How Grifols makes money
Grifols earns revenue from plasma-derived medicines and other healthcare products sold across the healthcare market. Spain is the company's home market on October 26, 2026. Market context: Market report IBEX 35.
Disclaimer...
en | ES0171996087 | GRIFOLS | boerse | 70412701 |
